Fusion event
HBV-chr5 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCT| |GCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGC
End
13358964/13358852 (Hg38)
Nearest miRNA
hsa-mir-10397/Upstream/2880707; hsa-mir-103a-1/Downstream/1467077;
Upstream sequence
CTTAATTTTAAAAAGTTTTGTTTTGTTCTTTTACAGGAAGAAAATCTGGAACTACTGACAATGTAATGATTAAAAATGTGGAGTTAAAGCTCAAGAGGAA
Downstream sequence
ccagaacctctccgccccaatttatctgtaagacagggatgataatagtccatgcttcatggtattatttgagagaatgaaGACAATTTACTTCTAATAA
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.